VASCULAR DEMENTIA - DIAGNOSTIC-CRITERIA FOR RESEARCH STUDIES - REPORT OF THE NINDS-AIREN INTERNATIONAL WORKSHOP

被引:4226
|
作者
ROMAN, GC
TATEMICHI, TK
ERKINJUNTTI, T
CUMMINGS, JL
MASDEU, JC
GARCIA, JH
AMADUCCI, L
ORGOGOZO, JM
BRUN, A
HOFMAN, A
MOODY, DM
OBRIEN, MD
YAMAGUCHI, T
GRAFMAN, J
DRAYER, BP
BENNETT, DA
FISHER, M
OGATA, J
KOKMEN, E
BERMEJO, F
WOLF, PA
GORELICK, PB
BICK, KL
PAJEAU, AK
BELL, MA
DECARLI, C
CULEBRAS, A
KORCZYN, AD
BOGOUSSLAVSKY, J
HARTMANN, A
SCHEINBERG, P
机构
关键词
D O I
10.1212/WNL.43.2.250
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily applicable in a variety of settings are urgently needed for both clinical and research purposes. To address this need, the Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke (NINDS) convened an International Workshop with support from the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), resulting in research criteria for the diagnosis of VaD. Compared with other current criteria, these guidelines emphasize (1) the heterogeneity of vascular dementia syndromes and pathologic subtypes including ischemic and hemorrhagic strokes, cerebral hypoxic-ischemic events, and senile leukoencephalopathic lesions; (2) the variability in clinical course, which may be static, remitting, or progressive; (3) specific clinical findings early in the course (eg, gait disorder, incontinence, or mood and personality changes) that support a vascular rather than a degenerative cause; (4) the need to establish a temporal relationship between stroke and dementia onset for a secure diagnosis; (5) the importance of brain imaging to support clinical findings; (6) the value of neuropsychological testing to document impairments in multiple cognitive domains; and (7) a protocol for neuropathologic evaluations and correlative studies of clinical, radiologic, and neuropsychological features. These criteria are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible). They await testing and validation and will be revised as more information becomes available.
引用
收藏
页码:250 / 260
页数:11
相关论文
共 23 条
  • [21] Validation Studies of the American College of Rheumatology (ACR) 2010 Fibromyalgia Diagnostic Criteria and the 2011 Self-Report Modification for Survey and Clinical Research
    Wolfe, Frederick
    Clauw, Daniel J.
    FitzCharles, MaryAnn
    Goldenerberg, Don
    Hauser, Winfried
    Katz, Robert S.
    Mease, Philip J.
    Russell, Anthony
    Russell, I. Jon
    Walitt, Brian
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [22] Mother-to-child transmission of HIV:: developing integration of healthcare programmes with clinical, social and basic research studies -: Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21-25 January 2003
    Menu, E
    Scarlatti, G
    Barré-Sinoussi, F
    Gray, G
    Bollinger, B
    Ioannidis, JPA
    Miotti, P
    Osborne, C
    ACTA PAEDIATRICA, 2003, 92 (11) : 1343 - 1348
  • [23] Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
    Schoettler, M. L.
    Carreras, E.
    Cho, B.
    Dandoy, C. E.
    Ho, V. T.
    Jodele, S.
    Moissev, I.
    Sanchez-Ortega, I.
    Srivastava, A.
    Atsuta, Y.
    Carpenter, P.
    Koreth, J.
    Kroger, N.
    Ljungman, P.
    Page, K.
    Popat, U.
    Shaw, B. E.
    Sureda, A.
    Soiffer, R.
    Vasu, S.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 151 - 163